⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions
businesswire.com
LLY
Lilly's oral GLP-1 Foundayo (orforglipron) delivered superior A1C control and weight loss in three pivotal type 2 diabetes trials
prnewswire.com
LLY
Retool Achieves AWS Consumer Goods Competency
businesswire.com
AMZN
COIN
DDOG
ADBE
NFLX
AAPL
GOOG
CHTR
NVDA
MSFT
INTC
AMD
TSLA
META
CRM
IBM
ORCL
CSCO
ACN
PYPL
UPST
PLTR
SNOW
CRWD
PANW
ZS
MDB
AFRM
SOFI
UPWK
FIVN
DOCU
SMCI
ASML
AMAT
KLAC
LRCX
MU
WDC
NXPI
QCOM
MRVL
ADSK
CDNS
SNPS
AMGN
GILD
BMY
LLY
REGN
VRTX
BIIB
AZN
XOM
CVX
SHEL
T
VZ
TMUS
CMCSA
DIS
GOOGL
AdvanCell Strengthens Executive Leadership to Accelerate U.S. Expansion and Scale its Global Targeted Alpha Therapy Platform
businesswire.com
JNJ
LLY
Questex’s Fierce Life Sciences Announces the 2026 Partnerships with Sites Summit Agenda
globenewswire.com
LLY
BIIB
AZN
BMY
MRK
TEVA
MitoRx Therapeutics presents promising preclinical data on MTRX31, a mitochondrial-targeted small molecule for metabolically unhealthy obesity, at the American Diabetes Association’s 2026 Scientific Sessions
globenewswire.com
LYFT
NVS
LLY
RARE
ADOCIA Announces THDB0206 (BioChaperone ® Lispro) Phase 3 Data in Type 2 Diabetes Presented at ADA 86th Scientific Sessions, Confirming the Positive Results Previously Announced in July 2025
businesswire.com
LLY
Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause
prnewswire.com
LLY
Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications
prnewswire.com
LLY
AI Integration in Biorefinery Operations to Drive $400M+ in Annual Savings as Industry Pursues Carbon Neutrality Goals
globenewswire.com
SHEL
LLY
NOV
XOM
CVX
BG
GEVO